UnknownNot Applicable

Abortion-related Morbidity and Mortality in Conflict-affected and Fragile Settings Study

Central African Republic, Democratic Republic of the Congo, Nigeria2,500 participantsStarted 2019-09-03

Plain-language summary

To describe and estimate the burden of abortion-related complications, particularly near-miss complications and deaths, and their associated factors among women presenting for abortion-related complications in health facilities supported by Médecins Sans Frontières (MSF) in African fragile and/or conflict-affected settings.

Who can participate

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

MEDICAL RECORD REVIEW: Inclusion Criteria: Women * with any signs or symptoms of abortion-related complications, i.e. any signs or symptoms of complications of spontaneous or induced abortion, whatever the abortion stage: inevitable, missed, incomplete, complete abortion . * Or with a presentation primary diagnosis of ectopic pregnancy or molar pregnancy Exclusion Criteria: * Threatened abortion (defined as vaginal bleeding with a closed cervix after having excluded the diagnosis of ectopic pregnancy or molar pregnancy) * History of abortion-related complications and presenting for an unrelated issue * Refusal to participate QUANTITATIVE INTERVIEW: Inclusion criteria: all women included in the medical record review subcomponent and hospitalized (who stayed overnight or more) Exclusion criteria: Participation to the interview as potentially harmwful to the woman according to her health care provider, Refusal to participate. QUALITATIVE INTERVIEW: Inclusion criteria: Women eligible for the quantitative interview and who experienced at least 1 criterion of near-miss event or potentially life-threatening conditions Exclusion criteria: Participation to the interview as potentially harmwful to the woman according to her health care provider, Refusal to participate. RAPID FACILITY ASSESSMENT: Key-informant: the provider in charge of the service providing post-abortion care KAPB SURVEY: Inclusion criteria: Health professionals (i.e. doctors, midwives, clinical offic…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

From the Quantitative observational descriptive study:

Timeframe: Between september 2019 and February 2021

Trial details

NCT IDNCT04331847

SponsorEpicentre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-03-15

View on ClinicalTrials.gov More Abortion Complication trials

Plain-language summary

Who can participate

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.